Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Related Citations for PubMed (Select 22156787)

1.

Spinal muscular atrophy type III: trying to understand subtle functional change over time--a case report.

Dunaway S, Montes J, Ryan PA, Montgomery M, Sproule DM, De Vivo DC.

J Child Neurol. 2012 Jun;27(6):779-85. doi: 10.1177/0883073811425423. Epub 2011 Dec 7.

PMID:
22156787
2.

The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy.

Nelson L, Owens H, Hynan LS, Iannaccone ST; AmSMART Group.

Neuromuscul Disord. 2006 Jun;16(6):374-80. Epub 2006 May 2.

PMID:
16632361
3.

Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year.

Kaufmann P, McDermott MP, Darras BT, Finkel R, Kang P, Oskoui M, Constantinescu A, Sproule DM, Foley AR, Yang M, Tawil R, Chung W, Martens B, Montes J, O'Hagen J, Dunaway S, Flickinger JM, Quigley J, Riley S, Glanzman AM, Benton M, Ryan PA, Irvine C, Annis CL, Butler H, Caracciolo J, Montgomery M, Marra J, Koo B, De Vivo DC; Muscle Study Group; Pediatric Neuromuscular Clinical Research Network for Spinal Muscular Atrophy.

Arch Neurol. 2011 Jun;68(6):779-86. doi: 10.1001/archneurol.2010.373. Epub 2011 Feb 14.

4.

Spinal muscular atrophy: survival pattern and functional status.

Chung BH, Wong VC, Ip P.

Pediatrics. 2004 Nov;114(5):e548-53. Epub 2004 Oct 18.

PMID:
15492357
5.

Prospective cohort study of spinal muscular atrophy types 2 and 3.

Kaufmann P, McDermott MP, Darras BT, Finkel RS, Sproule DM, Kang PB, Oskoui M, Constantinescu A, Gooch CL, Foley AR, Yang ML, Tawil R, Chung WK, Martens WB, Montes J, Battista V, O'Hagen J, Dunaway S, Flickinger J, Quigley J, Riley S, Glanzman AM, Benton M, Ryan PA, Punyanitya M, Montgomery MJ, Marra J, Koo B, De Vivo DC; Muscle Study Group (MSG); Pediatric Neuromuscular Clinical Research Network for Spinal Muscular Atrophy (PNCR).

Neurology. 2012 Oct 30;79(18):1889-97. doi: 10.1212/WNL.0b013e318271f7e4. Epub 2012 Oct 17.

6.

The predictive value of achieved motor milestones assessed in 441 patients with infantile spinal muscular atrophy types II and III.

Rudnik-Schöneborn S, Hausmanowa-Petrusewicz I, Borkowska J, Zerres K.

Eur Neurol. 2001;45(3):174-81.

PMID:
11306862
7.
8.

Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study.

Werlauff U, Vissing J, Steffensen BF.

Neuromuscul Disord. 2012 Dec;22(12):1069-74. doi: 10.1016/j.nmd.2012.06.352. Epub 2012 Nov 3.

PMID:
23127961
9.

SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy.

Kissel JT, Scott CB, Reyna SP, Crawford TO, Simard LR, Krosschell KJ, Acsadi G, Elsheik B, Schroth MK, D'Anjou G, LaSalle B, Prior TW, Sorenson S, Maczulski JA, Bromberg MB, Chan GM, Swoboda KJ; Project Cure Spinal Muscular Atrophy Investigators' Network.

PLoS One. 2011;6(7):e21296. doi: 10.1371/journal.pone.0021296. Epub 2011 Jul 6.

10.

Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy.

Febrer A, Rodriguez N, Alias L, Tizzano E.

J Rehabil Med. 2010 Mar;42(3):228-31. doi: 10.2340/16501977-0507.

11.

Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study.

Kirschner J, Schorling D, Hauschke D, Rensing-Zimmermann C, Wein U, Grieben U, Schottmann G, Schara U, Konrad K, Müller-Felber W, Thiele S, Wilichowski E, Hobbiebrunken E, Stettner GM, Korinthenberg R.

Neuromuscul Disord. 2014 Feb;24(2):134-42. doi: 10.1016/j.nmd.2013.10.011. Epub 2013 Nov 13.

PMID:
24300782
12.

Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III.

Glanzman AM, O'Hagen JM, McDermott MP, Martens WB, Flickinger J, Riley S, Quigley J, Montes J, Dunaway S, Deng L, Chung WK, Tawil R, Darras BT, De Vivo DC, Kaufmann P, Finkel RS; Pediatric Neuromuscular Clinical Research Network for Spinal Muscular Atrophy (PNCR); Muscle Study Group (MSG).

J Child Neurol. 2011 Dec;26(12):1499-507. doi: 10.1177/0883073811420294. Epub 2011 Sep 21.

PMID:
21940700
13.

Natural history of SMA IIIb: muscle strength decreases in a predictable sequence and magnitude.

Deymeer F, Serdaroglu P, Parman Y, Poda M.

Neurology. 2008 Aug 26;71(9):644-9. doi: 10.1212/01.wnl.0000324623.89105.c4.

PMID:
18725590
14.

Muscle fatigue in spinal muscular atrophy.

Iannaccone ST, White M, Browne R, Russman B, Buncher R, Samaha FJ.

J Child Neurol. 1997 Aug;12(5):321-6.

PMID:
9378900
15.

Clinical outcome measures in spinal muscular atrophy.

Montes J, Gordon AM, Pandya S, De Vivo DC, Kaufmann P.

J Child Neurol. 2009 Aug;24(8):968-78. doi: 10.1177/0883073809332702. Epub 2009 Jun 9. Review.

PMID:
19509409
16.

Prospective study of spinal muscular atrophy before age 6 years. DCN/SMA Group.

Iannaccone ST, Browne RH, Samaha FJ, Buncher CR.

Pediatr Neurol. 1993 May-Jun;9(3):187-93.

PMID:
8352849
17.

Muscle strength and motor function in children and adolescents with spinal muscular atrophy II and III.

Kroksmark AK, Beckung E, Tulinius M.

Eur J Paediatr Neurol. 2001;5(5):191-8.

PMID:
11585107
18.

Outcome measures for pediatric spinal muscular atrophy.

Iannaccone ST; American Spinal Muscular Atrophy Randomized Trials (AmSMART) Group.

Arch Neurol. 2002 Sep;59(9):1445-50.

PMID:
12223032
19.

A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients.

Zerres K, Rudnik-Schöneborn S, Forrest E, Lusakowska A, Borkowska J, Hausmanowa-Petrusewicz I.

J Neurol Sci. 1997 Feb 27;146(1):67-72.

PMID:
9077498
20.

Sleep disordered breathing in spinal muscular atrophy.

Mellies U, Dohna-Schwake C, Stehling F, Voit T.

Neuromuscul Disord. 2004 Dec;14(12):797-803.

PMID:
15564035
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk